Results 291 to 300 of about 1,433,283 (333)

Integrating next generation sequencing in measurable residual disease detection and prognostic stratification of acute myeloid leukemia and myelodysplastic neoplasm

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Simple Hysterectomy for Residual Cervical Intraepithelial Neoplasm

Journal of Lower Genital Tract Disease, 2018
Objective Many patients undergo hysterectomy for the treatment of cervical dysplasia. Factors that correlate with residual high-grade squamous intraepithelial lesions (HGSIL) at hysterectomy are not clear. We set out to determine preoperative features that may predict residual disease for patients treated for cervical dysplasia.
L. Binyamin, M. Segev, Y. Peled, H. Krissi, G. Sabah, O. Raban, A. Jakobson-Setton, A. Ben-Haroush, R. Eitan   +8 more
semanticscholar   +3 more sources

Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapy

The Prostate, 1993
AbstractThe incidence of residual neoplastic cells on prostatic biopsy following conventional external beam radiotherapy is reported to range from 40–90%. As a result, it has been stated that current modalities of radiotherapy may carry an unacceptable local failure rate even in patients irradiated for low stage disease.
J. Forman, Tracy Oppenheim, Henry Liu, J. Montie, P. Mclaughlin, A. Porter   +5 more
semanticscholar   +3 more sources

Low‐dose subcutaneous interleukin‐2 in patients with minimal residual lymphoid neoplasm disease

European Journal of Haematology, 1999
Abstract:  Interleukin‐2 (IL‐2) is a cytokine that became available for clinical use with the development of recombinant DNA technology. Patients with resistant or relapsed lymphoid neoplasm have been treated with high‐dose IL‐2 with some responses. The aim of the present study is to determine whether there may be a biological justification for the use
E. González-Barca, A. Grañena, A. Fernández-Sevilla, V. Moreno, A. Salar, F. Rueda, J. García   +6 more
semanticscholar   +3 more sources

Clinical outcomes of no residual disease in the specimen after endoscopic resection for gastric neoplasms

Surgical Endoscopy, 2016
No residual disease (NRD) can be found in the specimen after endoscopic resection (ER) of biopsy-proven gastric neoplasm. This study aimed to evaluate the endoscopic and pathologic characteristics of patients with NRD and identify the cause and long-term prognosis.Medical records of patients who underwent ER for biopsy-proven gastric neoplasms at a ...
J. Choi, S. Kim, Hyo-Joon Yang, Joo Hyun Lim, Jeongmin Choi, J. Im, J. S. Kim, Woo Ho Kim, H. Jung   +8 more
semanticscholar   +3 more sources

Photodynamic therapy for residual neoplasms of the perianal skin

Diseases of the Colon & Rectum, 2000
The aim of this study was to evaluate the efficacy of photodynamic therapy in the management of residual neoplasms of the perianal skin.This is a retrospective review. Five patients with pathologic confirmation of residual perianal neoplasms were treated with photodynamic therapy. There were three females.
M A, Runfola, T K, Weber, M A, Rodriguez-Bigas, T J, Dougherty, N J, Petrelli   +4 more
openaire   +2 more sources

Gastric Pathology Image Recognition Based on Deep Residual Networks

Annual International Computer Software and Applications Conference, 2018
Gastric cancer is a malignant neoplasm with a high mortality rate in the world. Nearly one million new cases occur each year. The most important measure to diagnose gastric cancer is the detection and treatment of diseases early. Gastric cancer detection
Bo Liu, Kelu Yao, Mengmeng Huang, Jiahui Zhang, Yong Li, Ronghua Li   +5 more
semanticscholar   +1 more source

Magnifying endoscopy for diagnosis of residual/local recurrent gastric neoplasms after previous endoscopic treatment

Surgical Endoscopy, 2012
Incomplete resection of gastric neoplasms by endoscopic treatment could lead to residual/local recurrence, which may be difficult to identify. This study aimed to evaluate the usefulness of magnifying endoscopy for identifying and demarcating residual/local recurrent gastric neoplasms after endoscopic treatment.Between December 2004 and November 2010 ...
Ryo, Kosaka, Kyosuke, Tanaka, Shunsuke, Tano, Reiko, Takayama, Kenichiro, Nishikawa, Yasuhiko, Hamada, Hideki, Toyoda, Katsuhito, Ninomiya, Masaki, Katsurahara, Hiroyuki, Inoue, Noriyuki, Horiki, Naoyuki, Katayama, Yoshiyuki, Takei   +12 more
openaire   +2 more sources

Feasibility of underwater endoscopic mucosal resection and management of residues for superficial non‐ampullary duodenal epithelial neoplasms

Digestive Endoscopy, 2019
Background and AimUnderwater endoscopic mucosal resection (UEMR) is effective for superficial non‐ampullary duodenal epithelial neoplasms (SNADEN). However, the incidence of residual lesion after UEMR, especially for large lesions (≥20 mm), and their prognosis remain unclear.
Hiroyoshi Iwagami, Yoji Takeuchi, Yasushi Yamasaki, Kentaro Nakagawa, Masayasu Ohmori, Kenshi Matsuno, Shuntaro Inoue, Taro Iwatsubo, Hiroko Nakahira, Noriko Matsuura, Satoki Shichijo, Akira Maekawa, Takashi Kanesaka, Koji Higashino, Noriya Uedo, Ryu Ishihara   +15 more
openaire   +2 more sources

A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasms

Journal of Cancer Research and Clinical Oncology, 2021
To elucidate whether portal venous tumor invasion (PVTI) is a prognostic factor for patients with pancreatic neuroendocrine neoplasms (Pan-NENs).From 2002 to 2019, 240 patients with Pan-NEN were included to examine prognostic factors. PVTI based on computed tomography (CT) images are classified into four types: no PVTI (Vp0/1), PVTI not invading the ...
Tomotaka Kato, Atsushi Kudo, Yuko Kinowaki, Yoshiya Ishikawa, Shuichi Watanabe, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Minoru Tanabe   +10 more
openaire   +2 more sources